NDC 62742-4195-02: DermaClear BHA Spot Treatment Salicylic Acid 2 mg/g Gel, 4.8 g Bottle
This is a package of 1 bottle of DermaClear BHA Spot Treatment Salicylic Acid 2 mg/g Gel from Allure Labs, first listed with the FDA Dec 2020 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 62742-4195-2 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 62742 labeler · 4195 product · 2 package
- Package marketed since
- Dec 10, 2020
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 6274241952 7
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
DermaClear BHA Spot Treatment is a topical gel containing salicylic acid, an over-the-counter skin care product sold under FDA's established rules for this category. Salicylic acid is commonly used in acne treatments to help loosen dead skin cells and reduce oiliness on the skin surface. This product is intended for spot application to affected areas rather than full-face use. As an OTC monograph drug, it follows standardized formulation guidelines for topical acne treatments.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 62742-4195-02 You're viewing this Main listing | 1 BOTTLE, WITH APPLICATOR in 1 CARTON / 4.8 g in 1 BOTTLE, WITH APPLICATOR Inner NDC 62742-4195-1 · each with applicator bottle (4.8 g) | 2020-12-10 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| DermaClear BHA Spot Treatment 2 mg/gthis 62742-4195-02 | Allure | 1 bottle | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 3K9958V90M
A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
-
UNII 3XUS85K0RA
Butylene glycol is a clear liquid derived from petroleum or plants that acts as a humectant, solvent, and preservative booster in medicines. It helps keep formulations stable, dissolve active ingredients, and maintain moisture in topical products.
-
UNII 9XZ8H6N6OH
A plant-based cellulose derivative used as a binder to hold tablet ingredients together, a thickener in liquids, and a coating agent to control how fast the medicine dissolves.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
4 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Allure Labs labeler code 62742
- Everyday Sheer Coverage Light Tint SPF 20 Zinc Oxide 177 mg/mL Cream NDC 62742-4159-2
- Everyday Sheer Coverage Medium Tint SPF 20 Zinc Oxide 177 mg/mL Cream NDC 62742-4160-2
- Acne LotionSulfur Sulfur 30 mg/mL Lotion NDC 62742-4169-1
- Skin Soothing Cream Colloidal Oatmeal 1 mg/g Cream NDC 62742-4190-1
- Skin Renewing Cream Salicylic Acid 1.8 mg/g Cream NDC 62742-4193-1
- Skin Soothing Cream - Nut Free Colloidal Oatmeal 1 mg/g Cream NDC 62742-4194-1
- CBD Blue Light Defense SPF 30 Zinc Oxide 189 mg/g Cream NDC 62742-4196-1
- CBD Pain Relief Cream Trolamine Salicylate 100 mg/g Cream NDC 62742-4198-1
- Sheer Zinc SPF 30 Zinc Oxide 186 mg/g Cream NDC 62742-4199-2
- Clear Cell Clarifying Acne Benzoyl peroxide 50 mg/g Lotion NDC 62742-4208-1
- Broad Spectrum SPF30 Mineral Sunscreen Zinc Oxide 21 g/100g Cream NDC 62742-4209-1
- Acne Oil Control Primer Salicylic Acid 20 mg/g Liquid NDC 62742-4211-2
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses: For the treatment of acne.
⏱️ Dosage and Administration ▾
Directions Apply a small portion over the affected area with finger tips and gently massage onto the skin. Reapply as needed.
⚠️ Warnings ▾
Warnigs For external use only
🧪 Active Ingredient ▾
Active Ingredient: Salicylic Acid - 2%
🧪 Inactive Ingredients ▾
Other ingredients: Water (aqua), SD Alcohol 40-B, Butylene Glycol, Hydroxypropylcellulose
🎯 Purpose ▾
Purpose: Acne Treatment
📄 When Using This Product ▾
When using this product Avoid contact with eyes, lips and mouth. Using other topical acne medication at the same time ot immefiately following use of this product may increase dryness or irritation of the skin. If this occurs only one medication should be used unless directed by a doctor. If sensitive to the sun or when increased sun exposure is expected use a sunscreen.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor: If severe skin irritation occurs. Using other topical medication at the same time
📄 Keep Out of Reach of Children ▾
Keep out of reach of children: If swallowed, get medical help or contact a Poison Control Centre right away.
📄 Package Label / Principal Display Panel ▾
Manufactured For Dermaquest ®, Inc. Hayward, CA 94544 1272 GK, NL Made in USA dermaquestinc.com IMGDQIDBHAST
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |